Esmolol

Half-Life (t½)
IV: 9m
Formula
C16H25NO4
Molecular Weight
295.38 g/mol
PubChem CID
59768
Aliases
Brevibloc

Pharmacological Mechanism

Ultra-short-acting cardioselective β1 blocker — esterase-mediated hydrolysis gives ~9 min half-life. IV-only; titratable for acute hypertensive emergencies, intraoperative tachycardia, AF rate control where rapid offset is needed.

Half-Life & Elimination Curve (IV: 9m)

100%50%25%12.5%0%0h0×t½9m1×t½18m2×t½27m3×t½36m4×t½45m5×t½0×t½ (0h): 100% remaining (~0.42 µg/L)1×t½ (9m): 50% remaining (~0.21 µg/L)2×t½ (18m): 25% remaining (~0.105 µg/L)3×t½ (27m): 12.5% remaining (~0.0525 µg/L)4×t½ (36m): 6.3% remaining (~0.0263 µg/L)5×t½ (45m): 3.1% remaining (~0.0131 µg/L)
Elimination (IV)
  • 0×t½0h100% (0.42 µg/L)
  • 1×t½9m50% (0.21 µg/L)
  • 2×t½18m25% (0.105 µg/L)
  • 3×t½27m12.5% (0.0525 µg/L)
  • 4×t½36m6.3% (0.0263 µg/L)
  • 5×t½45m3.1% (0.0131 µg/L)
Elimination t½9m (IV)
Rate Constant (ke)4.62 h⁻¹
Est. Peak (Cmax)0.42 µg/L
Clearance (CL)1100 L/h
97% Washout (5×t½)45m

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References